How Safe is the Readministration of Streptokinase?

This publication has 23 references indexed in Scilit:

• Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.
  Heart, 1994
• Antistreptokinase antibodies before and after streptokinase therapy in patients with acute myocardial infarction from areas endemic for streptococcal infection and influence on reperfusion rates
  The American Journal of Cardiology, 1994
• Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction
  The American Journal of Cardiology, 1993
• Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase
  European Heart Journal, 1993
• Streptokinase resistance: when might streptokinase administration be ineffective?
  Heart, 1992
• Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG
  Heart, 1992
• GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
  1990
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).
  1986
• Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: Implications regarding therapy
  The American Journal of Cardiology, 1984